Yeah I saw that... and thought to myself "Gee, didn't we hear that statement before and then waited, waited and watied some more!". I'm not phased because the wait for CellPryme-M was well worth it... and I'm confident that CP-A will be equally stellar!
Whilst you're here, @hottod, what's you're view on the non-viral vector approach and its tie to the TFS deal? I found an insightful article on the subject of the two different types of vectors and the move towards non-viral but the challenges.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347098/#b33
In fact, this site is coming in more and more handy for me.
Yeah I saw that... and thought to myself "Gee, didn't we hear...
-
- There are more pages in this discussion • 907 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
